Mosunetuzumab and lymphoma: latest updates from 2022 ASH annual meeting

por Cao, Yang, Marcucci, Emanuela C., Budde, Lihua E.
Publicado 2023

Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy

por Urak, Ryan, Walter, Miriam, Lim, Laura, Wong, ChingLam W., Budde, Lihua E., Thomas, Sandra, Forman, Stephen J., Wang, Xiuli
Publicado 2017

Bendamustine, etoposide, and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in non-Hodgkin lymphoma

por Greenbaum, Adam M., Green, Damian J., Holmberg, Leona A., Gooley, Ted, Till, Brian G., Budde, Lihua E., Rasmussen, Heather, Press, Oliver W., Gopal, Ajay K.
Publicado 2018

Dose-finding study of ibrutinib and venetoclax in relapsed or refractory mantle cell lymphoma

por Portell, Craig A., Wages, Nolan A., Kahl, Brad S., Budde, Lihua E., Chen, Robert W., Cohen, Jonathon B., Varhegyi, Nikole E., Petroni, Gina R., Williams, Michael E.
Publicado 2022

A phase 2, multicentre, open‐label trial (ACE‐LY‐003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma

por Strati, Paolo, Coleman, Morton, Champion, Rebecca, Ma, Shuo, Patti, Caterina, Levy, Moshe Y., Lossos, Izidore S., Geethakumari, Praveen Ramakrishnan, Lam, Selay, Calvo, Roser, Higgins, Kara, Budde, Lihua E.
Publicado 2022

Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma

por Budde, Lihua E., Berger, Carolina, Lin, Yukang, Wang, Jinjuan, Lin, Xubin, Frayo, Shani E., Brouns, Shaunda A., Spencer, David M., Till, Brian G., Jensen, Michael C., Riddell, Stanley R., Press, Oliver W.
Publicado 2013

Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma

por Ladbury, Colton, Dandapani, Savita, Hao, Claire, Fabros, Mildred, Amini, Arya, Sampath, Sagus, Glaser, Scott, Sokolov, Karen, Yeh, Jekwon, Baird, John H., Kambhampati, Swetha, Herrera, Alex, Mei, Matthew, Nikolaenko, Liana, Shouse, Geoffrey, Budde, Lihua E.
Publicado 2023

Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma

por Green, Damian J., Bensinger, William I., Holmberg, Leona A., Gooley, Ted, Till, Brian G., Budde, Lihua E., Pagel, John M., Frayo, Shani L., Roden, Jennifer E., Hedin, Lacey, Press, Oliver W., Gopal, Ajay K.
Publicado 2016

Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma

por Sidana, Surbhi, Hosoya, Hitomi, Jensen, Alexandria, Liu, Lawrence, Goyal, Anmol, Hovanky, Vanna, Sahaf, Bita, Bharadwaj, Sushma, Latchford, Theresa, Arai, Sally, Leahy, Sheryl, Mei, Matthew, Budde, Lihua E., Muffly, Lori S., Frank, Matthew J., Dahiya, Saurabh, Htut, Myo, Miklos, David, Janakiram, Murali
Publicado 2023

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

por Locke, Frederick L., Neelapu, Sattva S., Bartlett, Nancy L., Siddiqi, Tanya, Chavez, Julio C., Hosing, Chitra M., Ghobadi, Armin, Budde, Lihua E., Bot, Adrian, Rossi, John M., Jiang, Yizhou, Xue, Allen X., Elias, Meg, Aycock, Jeff, Wiezorek, Jeff, Go, William Y.
Publicado 2017

Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma

por Bartlett, Nancy L., Assouline, Sarit, Giri, Pratyush, Schuster, Stephen J., Cheah, Chan Y., Matasar, Matthew, Gregory, Gareth P., Yoon, Dok Hyun, Shadman, Mazyar, Fay, Keith, Yoon, Sung-Soo, Panizo, Carlos, Flinn, Ian, Johnston, Anna, Bosch, Francesc, Sehn, Laurie H., Wei, Michael C., Yin, Shen, To, Iris, Li, Chi-Chung, Huang, Huang, Kwan, Antonia, Penuel, Elicia, Budde, Lihua E.
Publicado 2023

Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study

por Budde, Lihua E., Assouline, Sarit, Sehn, Laurie H., Schuster, Stephen J., Yoon, Sung-Soo, Yoon, Dok Hyun, Matasar, Matthew J., Bosch, Francesc, Kim, Won Seog, Nastoupil, Loretta J., Flinn, Ian W., Shadman, Mazyar, Diefenbach, Catherine, O'Hear, Carol, Huang, Huang, Kwan, Antonia, Lin, Chi-Chung, Piccione, Emily C., Wei, Michael C., Yin, Shen, Barlett, Nancy L.
Publicado 2022

Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma

por Zurko, Joanna, Ramdial, Jeremy, Shadman, Mazyar, Ahmed, Sairah, Szabo, Aniko, Iovino, Lorenzo, Tomas, Ana Alarcon, Sauter, Craig, Perales, Miguel-Angel, Shah, Nirav. N., Acharya, Utkarsh H., Jacobson, Caron, Soiffer, Robert J., Wang, Trent, Komanduri, Krishna V., Jaglowski, Samantha, Kittai, Adam S., Denlinger, Nathan, Iqbal, Madiha, Kharfan-Dabaja, Mohamed A., Ayala, Ernesto, Chavez, Julio, Jain, Michael, Locke, Frederick L., Samara, Yazeed, Budde, Lihua E., Mei, Matthew G., Pia, Alexandra Della, Feldman, Tatyana, Ahmed, Nausheen, Jacobs, Ryan, Ghosh, Nilanjan, Dholaria, Bhagirathbhai, Oluwole, Olalekan O., Hess, Brian, Hassan, Ayesha, Kenkre, Vaishalee P., Reagan, Patrick, Awan, Farrukh, Nieto, Yago, Hamadani, Mehdi, Herrera, Alex F.
Publicado 2022